title: Warner-Lambert voluntarily withdraws Rezulin.
mesh_terms: D002839:Chromans / Q000009:adverse effects* / Q000627:therapeutic use; D003257:Consumer Product Safety; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004345:Drug Industry; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D013844:Thiazoles / Q000009:adverse effects* / Q000627:therapeutic use; D045162:Thiazolidinediones; D000077288:Troglitazone; D014481:United States
chemical_list: D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone